Edition:
India

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

1.10USD
16 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.10
Open
--
Day's High
--
Day's Low
--
Volume
197,724
Avg. Vol
212,488
52-wk High
$15.95
52-wk Low
$0.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 5.04 -0.911
FY 2018 Dec '18 3.67 -0.993
Sep '18 1.63 -1.057
Jun '18 3.68 -1.009
Mar '18 1.12 -0.979
FY 2017 Dec '17 1.00 -0.802
Sep '17 0.68 -0.631
Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 5 5.78 6.20 5.20 20.30
Quarter Ending Dec-19 5 6.44 8.00 5.40 23.00
Year Ending Dec-19 5 22.83 25.80 20.80 70.59
Year Ending Dec-20 5 35.15 53.90 19.90 160.54
Earnings (per share)
Quarter Ending Sep-19 4 -0.71 -0.68 -0.73 --
Quarter Ending Dec-19 4 -0.55 -0.34 -0.67 --
Year Ending Dec-19 4 -2.87 -2.47 -3.11 -3.25
Year Ending Dec-20 4 -2.38 -1.50 -2.81 -1.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 499.58 -- --
EPS (TTM) % -61.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -20.09 -22.31 36 --
13 Week -75.21 -75.92 8 --
26 Week -73.88 -77.00 16 --
52 Week -90.63 -91.21 15 --
YTD -76.32 -80.38 14 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 95.42%
# of Holders: 141
Total Shares Held: 39,383,337
3 Mo. Net Change: 1,049,096
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 7
# Reduced Positions: 8
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.